chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a medical assistant refers to a 31 year old patient of an unknown gender. Information regarding the patient's pertinent medical history, drug reaction/allergies and concomitant medications was not reported. On an unknown date, while the patient was still 26 years of age or under, the patient was vaccinated with first two doses of GARDASIL (lot number, expiration date, dose and route of administration were not reported). On 31-AUG-2015, the patient was in the office to receive their third dose of GARDASIL (lot number: L004014, expiration date: 04-MAR-2017, dose and route of administration were not reported) at 31 years of age. No adverse effects was reported. There was no product quality complaint. The outcome of the event was not reported. Additional information has been requested.
Patient reported feeling numbness to the lips, mouth, upper palate and throat as well as feeling like someone was "choking her". She didn't appear to be in respiratory distress but reported that she had had a severe allergic reaction to the shingles vaccine one month ago, and that these were the same symptoms she felt at that time before it escalated. Patient was given epinephrine autoinjection 0.3 mg to the right thigh and EMS was called. Patient was transferred to ED. Patient remained conscious, breathing stable and able to speak the entire time.
walking pneumonia after getting the flu shot; the patient was sick for 3 months; Initial information regarding this unsolicited valid non-serious social media case received from a consumer (patient) on 07-Dec-2020.   This case involves a patient with unknown demographics who experienced walking pneumonia (Atypical pneumonia) and the patient was sick for 3 months (illness), when received vaccine INFLUENZA VACCINE (flu shot).  Relevant medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.  At the time of the event, the patient had ongoing autoimmune disorder.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious walking pneumonia after getting the flu shot (atypical pneumonia) and was sick for 3 months (illness) unknown latency following the administration of INFLUENZA VACCINE.  Relevant laboratory test was not reported.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the reported events.  There will be no information available on batch number for this case.
Shingles; swollen lymph nodes; This is a spontaneous report from a non-contactable consumer (Patient). A 35-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 19Feb2021 (Lot Number: EN6201), (age at vaccination 35-year-old) as first dose, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not tested for covid post vaccination. On 23Feb2021, the patient experienced shingles, swollen lymph nodes. Therapeutic measures were taken as a result of shingles, swollen lymph nodes as antiviral (Valtrex). Patient did not experienced covid prior to vaccination. The outcome of events were recovering.   No follow-up attempts are possible. No further information is expected.
10 after injection, numbness left arm radiating to neck, numbness included throat, head (+) difficulty breathing, arm appeared red and swollen.
pt recv vax & devel shingles 10 days post vax;It was reported that pt case of shingles has resolved;
Day of vaccination - post, mild pain to site (L) deltoid, at night time pain increased "took ibuprofen, next day mild swelling with tenderness, mild to moderate pain, took ibuprofen 2 x day, 3rd day minimal redness below injection site at least 2-3 fingers below, minimal to mild tenderness, redness is getting bigger, pain minimal. No fever noted.
presented to reporting personnel facility ED from assisted living facility with weakness approximately 48 hours post vaccine.  previously ambulated with seated walker but too weak to do so at time of presentation.  Recovered in ED- returned to assisted living facility
Fridge temp went out of range by 4 degrees overnight on Sunday due to storm, Facility was closed 1/17. Vaccine was administered to patient
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was inoculated with ZOSTAVAX (lot number, dosage, and route of administration) on or about 23-OCT-2012, at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 12-APR-2016, the patient was treated for a painful rash that was diagnosed as shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Stinging sensation; Slight headache; Arm started hurting; Hands were tingling; Felt numb; Rapid heartbeat/ heart was racing; Chills on and off; Dizziness; Foggy feeling in brain; Vaccination site erythema; Bruised; Hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling) and HYPOAESTHESIA (Felt numb) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (Shrimp).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling), HYPOAESTHESIA (Felt numb), HEART RATE INCREASED (Rapid heartbeat/ heart was racing), CHILLS (Chills on and off), DIZZINESS (Dizziness), FEELING ABNORMAL (Foggy feeling in brain), VACCINATION SITE ERYTHEMA (Vaccination site erythema), CONTUSION (Bruised) and VACCINATION SITE WARMTH (Hot to the touch). At the time of the report, PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling), HYPOAESTHESIA (Felt numb), HEART RATE INCREASED (Rapid heartbeat/ heart was racing), CHILLS (Chills on and off), DIZZINESS (Dizziness), FEELING ABNORMAL (Foggy feeling in brain), VACCINATION SITE ERYTHEMA (Vaccination site erythema), CONTUSION (Bruised) and VACCINATION SITE WARMTH (Hot to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not reported  Treatment information was not provided
I received my second dose last month. I didn?t notice this symptom until maybe a week or two ago. But it seem to be more constant and it?s gotten to the point that for the last few days I am walking around thinking a tv, or light or fan or something electrical is on.   The reason being, I?m getting a constant high pitched tone in my right ear. It sounds almost like a high pitched dog whistle. If Will it ever go away.   Thanks in advance.
Ipol 0.1ml was given instead of Tubersol with no reported adverse event; nitial information was received on 06-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked to cases 2023SA043808 and 2023SA043813.  This case involves 56 years old female patient who experienced ipol 0.1ml was given instead of tubersol with no reported adverse event while receiving vaccine ipv (VERO) [Ipol].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 31-Jan-2023, the patient received a dose of suspect ipv (VERO) Suspension for injection at 0.1ml lot W1A191M at expiry of 16-Feb-2025 via intradermal route in the left forearm for immunization.  On 31-Jan-2023 the patient developed a non-serious event of ipol 0.1ml was given instead of tubersol with no reported adverse event (wrong product administered) following the administration of ipv (VERO).  Action taken with POLIOMYELITIS VACCINE (INACTIVATED) (Ipol) was not applicable.  It was not reported if the patient received a corrective treatment for the event (Ipol 0.1ml was given instead of Tubersol with no reported adverse event).  At time of reporting, the outcome was Unknown for the event ipol 0.1ml was given instead of tubersol with no reported adverse event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Pain and swelling at site. Swelling was unusally large. Patient described it over phone to the Pharmacy that she had a lump the size of small ball.
About 15 minutes after shot, fatigue and feeling wiped out. Painful sore arm seven hours later. Headaches ever since. Two days later and headaches, fatigue, wiped-out and painful sore arm are no better.
This spontaneous report as received from a pharmacist refers to a 3 years old female patient. The patient was 11 years old now. On an unknown date, the patient was vaccinated with 0.5 ml VARIVAX (merck) VIAL 1350U subcutaneously at 12 months of age. Lot# was unspecified. Two years later, on an unspecified date at approximately 3 years old, the patient developed immune thrombocytopenic purpura (ITP). The patient received treatment with intravenous immunoglobulins (specific products and manufacturers unspecified). The outcome of patient was unknown. Additional information is not expected.
Information has been received from a consumer concerning an "around 60 year old" female who was vaccinated with ZOSTAVAX (Merck) "single dose of series".  After receiving ZOSTAVAX (Merck) the patient came down with flu like symptoms, was very achy, very fatigue and had developed blisters on her back side.  The patient was diagnosed with shingles.  The patient's shingles persisted.  No further information is available. This is in follow-up report(s) previously submitted on 12/23/2008. Follow-up information was received from the consumer. The consumer reported the patient was also a nurse who in approximately December 2006 "about two year ago" received ZOSTAVAX (Merck) and then in approximately September 2008, "about two or three months" ago she came down with flu like symptoms and then developed a bad case of the shingles. The patient believed that because she fell a few times while hiking that trauma of falling may have caused the outbreak of singles she had. Follow-up information was received from the consumer. The patient said that she had gotten her vaccine 2 years prior to becoming ill and breaking out with shingles. She believes that at the time she received the vaccine that perhaps knowledge of refrigeration methods was not available that her vaccine may not have been effective for that reason. She was fine at the report time. This is one of several reports from the same source. Additional information is not expected.
Hospitalized with dyspnea,  neutropenic fever, COVID 19, treated with remdesivir, was septic on admit to outside facility with BP of 80/30, pulse 110, resolved prior to admit in PRIVATE, no need for supplemental oxygen.
I WAS ONLY ABLE TO ADMINISTER ONE-HALF OF THE DOSE OF THE FLU VACCINE. PATIENT EXPERIENCED EXTREME PAIN IN RIGHT ARM AND PULLED AWAY. PAIN EVENTUALLY SUBSIDED. I SPOKE TO PATIENT AT 4:25 PM (45 MINUTES LATER) ON PHONE AND PATIENT STATED SHE DID NOT FEEL PAIN ANYMORE.
Pt vaccinated with DTP developed urticaria 2 hrs after immunization, treated with Benadryl. This was child's second DTP. No reaction at 2 mo of age.
Pt vaccinated w/Influenza developed aggravation reaction. This involved exacerbation of her polymyalgia rheumatica. Admitted to hosp w/severe painful weakness in her proximal muscles. Given steroidal therapy approx six months later, weaned.
Vaccine recipient received vaccine on 12/19/2020.On 12/20 experienced symptoms of headache, fatigue, chills, fever 101.8 F, lower back pain, and nausea. The vaccine recipient took acetaminophen and managed symptoms at home. Reported to have slept for most of the day. On 12/22, during a follow-up phone call reported that most of the symptoms have subsided and only nausea remained.
20 Patients received Spikevax past the 30 day expiration date; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (20 Patients received Spikevax past the 30 day expiration date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 023C22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (20 Patients received Spikevax past the 30 day expiration date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (20 Patients received Spikevax past the 30 day expiration date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (20 Patients received Spikevax past the 30 day expiration date).    No concomitant medications were reported. No treatment information was provided. The case contains information of 7th patient out of 20 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-700683 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-700683:MASTER  CASE
On 7/7/99, the pt received his first IM-left deltoid dose of Lymerix.  Subsequently, he experienced discomfort and the sensation of heat at the injection site. These symptoms resolved after three weeks.  The most recent information received on 7/27/99, reports the condition of the pt is resolved.
Excruciating chest pain that doesn't come from food, alcohol, or vigorous exercise; This spontaneous case was reported by a patient and describes the occurrence of CHEST PAIN (Excruciating chest pain that doesn't come from food, alcohol, or vigorous exercise) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 045A21A) for COVID-19 vaccination.     Concurrent medical conditions included Sleep apnea.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced CHEST PAIN (Excruciating chest pain that doesn't come from food, alcohol, or vigorous exercise). At the time of the report, CHEST PAIN (Excruciating chest pain that doesn't come from food, alcohol, or vigorous exercise) had not resolved.            No concomitant medication provided.  No treatment medication provided.
Headache, Arthralgia, Fever, FATIGUE, CHILLS. PAIN/SWELLING INJ SITE,  LOCAL LYMPHNODE TENDER/SWELL Narrative:
With the first shot I have a scar on my right arm that looks almost like a red mole. With the second shot I had severe side affects at injection site. When shot was given extreme shock and tingling throughout entire body for loss than 20 seconds. I removed the bandaid the day after the shot was given and found a large blister at the injection site. It caused my skin to almost melt in on itself like if you got a rug burn or burned your hand on a hot pan. Arm still hurts over 48 hours after and it still swollen. Will have a scar from the injection
Body aches and nausea started at 8:30 pm Saturday (4/24/21)remained mild until 11:00pm Saturday when the aches increased in severity. By 6:30am Sunday, low grade fever and headache began.  No medications were taken so as to not interfere with the body's immune system.  Fever and aches increased until 1pm reaching 102 degrees.  Patient remained in bed or a recliner by necessity from 10:30 pm Saturday until 8pm Sunday.  By 5pm Sunday aches decreased in  intensity but fever remained.  By wake up at 6:30am on Monday, fever and aches were gone and patient returned to work.  Patient experienced slight fatigue and worked less intensively than usual on Monday.
This spontaneous report as received from a pharmacist refers to himself, a 60 year old male patient. Information about the patient's pertinent medical history, concomitant medications, drug reactions or allergies was not provided. On 27-MAR-2015, the patient was vaccinated with ZOSTAVAX, subcutaneously, lot # K020187 - expiration date: 27-JAN-2016 (strength, dosage schedule were not reported). On 25-JUN-2016, the patient experienced herpes zoster (reported as "shingles"). The patient was seen by his healthcare professional and was treated with acyclovir (manufacturer unknown) orally. No labs were performing.  On 11-JUN-2016, the patient recovered from the shingles. At the reporting time, he did not have lesions. The reporter did not assessed causality between the event and the use of ZOSTAVAX. Additional information has been requested.
Headache, Fever, FATIGUE; BODY ACHES; CHILLS Narrative:  Other Relevant History:
Initial information received on 31-Jan-2019 regarding an unsolicited valid non-serious case received from a physician. This case involves male patient of an unknown age who experienced pain, while he received vaccine ADACEL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect ADACEL lot number not reported via unknown route in unknown administration site. On an unknown date, the patient developed a non-serious pain six weeks following the administration of ADACEL. Two days ago he went to the ED and received an Ultrasound and it was negative. Final diagnosis was pain. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for pain. Documents held by sender: none.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. During 2015, the patient was inoculated at a pharmacy with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended. On or about 01-MAY-2016, the patient was treated and diagnosed with herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
1.  Numbness on right side of nose and under right eye.  Amoxicillin followed by Clavulanate starting 5/28/2021.  Clindamycin starting 6/23/2021.  Condition still exists.   2.  Atrial Flutter.  First detected on 7/27/2021.  Condition still exists.  Ablation scheduled for 10/15/2021. Atrial Flutter-Echocardiogram 8/9/2021.
I felt terrible, like I had the flu, with extreme fatigue and a headache. This lasted for 4 days. I also couldn't take a deep breath.
PT HAD HEP B VACCINE ON 10-7-13, THEN RASH APPEARED ON THE 16TH,  LOOK LIKE BABY ACNE ON FEET AND LEGS AND THE ARMS (JUST A COUPLE) LIKE BABY ACNE). AND NO OTHER S/S.BY THAT NIGHT MORE SPREAD AND THEN AT 4 AM ON THE 17TH SPREAD ALL OVER AND FEET SEEMED SWOLLEN, TAKEN TO ER, AND THOUGHT ETN AND BLOOD WK WNL, SWAB FLU, RSV BY END DAY OR 6 HOUR AFTER ED, RASH WORSE AND CHANGED IN APPERANCE. MOM DECIDED TO COME HOME AND FELT HOT AS IF SUNBURN. AND THEN DROVE STRAIGHT TO AP. THERE HAD A FULL WK UP AND ALL NEG. AND WAS OBSERVED AND RASH RESOLVED BUT GOT STEROID AND BENADRYL.(ADMITTED 5 AM) AND THEN AFTER ADMISSION ABOUT LATTER HIS RASH COMPLETLY RESOLVED. SINCE THEN DOING WELL NO OTHER SS.
Headaches, rash around injection site, lumps under skin, sore throat, diarrhea, fever and swollen glands in neck area.
Patient given 4th vaccination of Pfizer on 6/22. On 7/5 he developed symptoms and tested positive for COVID. Soon afterwards he started having chest tightness with exertion. Was found to have alternating bundle branch block on EKG on 8/25 and sent to hospital, urgent pacemaker placed 8/26.
patient got swelling and redness that was not at the shot site but lower on her arm near her elbow.
30 minutes post Pfizer COVID-19 Vaccine, burning/warm sensation in chest for 2-3 minutes. No pain.  Extreme Fatigue for 4 days post vaccine Severe Cotton Mouth for one week and ongoing Severe loss of apatite for a week and ongoing
BRUISING AT AND AROUND THE AREA OF INJECTION, BRUISING IS EVIDENT TODAY (2/14/16) IN AN AREA OF 4 INCH DIAMETER.  NO SWELLING OR HARDNESS OBSERVED.
Patient had sudden onset of chest pain at 2 am.  Patient described it as vague anterior chest pain.  Patient said he has been vaccinated and boosted for COVID19 but had a recent exposure.  Upon admission to the ER, he was tested and was found to be covid +.   CT showed a 5cm Ascending Thoracic Aorta with dissection which extends into the arch.  Patient currently in emergent surgery for possible bicuspid aortic valve replacement and stenting.
Patient began to feel real week and sweating just a few minutes in to vaccine. Became very pale. Called 911. Took his BP before they arrived. It was 105/60. He claimed that was low for him. He said he feels that way when blood sugar gets low. Paramedics arrived and took BP again had come up to 130/90. We were in the process of taking his sugar when they came and did it. It was 139. Patient felt better on his own really with some candy and water. He decided not to go with paramedics. I called and checked on him this evening and he was fine.
Immediately after the shot I got really dizzy. Then the severe dizziness continued for the next month. I was unable to eat, if I did I would throw it all up. I could sip on water and eat celery and watermelon. I did take Zofran ODT for the nausea, but it didn't help if I didn't take it soon enough. I was laid in bed and lost about 15 lbs in the month of June.